Lv31
320 积分 2023-08-27 加入
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
1小时前
已完结
Combination of NA, PEG-IFN alpha-2b and GM-CSF enhanced hbsab production in NA experienced CHB patients (the anchor a study): an interim analysis
1个月前
已完结
中国老年人生活习惯与抑郁症状的相关性研究
1个月前
已关闭
Fear of hypoglycemia
1个月前
已关闭
Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: a systematic review and meta-analysis
2个月前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
2个月前
已完结
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2个月前
已完结
Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update
3个月前
已完结
皖公网安备34019202002308
